[Therapy of peripheral circulatory disorders using BAY b 7979, demonstrated through Tc-99m muscular clearance].
D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007294:Inositol / Q000031:analogs & derivatives / Q000627:therapeutic use*; D007610:Kallikreins / Q000627:therapeutic use*; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D012039:Regional Blood Flow; D013667:Technetium
D009539:Nicotinic Acids; D007294:Inositol; D013667:Technetium; D007610:Kallikreins
Zur Therapie peripherer Durchblutungsstörungen mit BAY b 7979, objektiviert durch Tc-99m-Muskelclearance